(0.06%) 5 158.00 points
(0.08%) 38 862 points
(-0.04%) 17 994 points
(0.58%) $78.56
(0.37%) $2.15
(0.54%) $2 321.00
(1.98%) $27.22
(-0.04%) $964.90
(0.03%) $0.929
(-0.07%) $10.87
(0.01%) $0.797
(0.52%) $91.93
2.93% $ 2.11
Live Chart Being Loaded With Signals
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 553 607 |
Średni wolumen | 643 506 |
Kapitalizacja rynkowa | 34.05M |
EPS | $-0.560 ( 2024-02-15 ) |
Następna data zysków | ( $-0.660 ) 2024-05-21 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.710 |
ATR14 | $0.0180 (0.86%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-11 | Deveer Robert K Jr | Buy | 6 000 | Common Stock |
2024-03-06 | Deveer Robert K Jr | Sell | 1 685 | Common Stock |
2024-03-06 | Deveer Robert K Jr | Sell | 7 286 | Common Stock |
2024-03-06 | Deveer Robert K Jr | Sell | 200 | Common Stock |
2024-03-06 | Deveer Robert K Jr | Sell | 1 808 | Common Stock |
INSIDER POWER |
---|
47.51 |
Last 100 transactions |
Buy: 594 391 | Sell: 320 931 |
Wolumen Korelacja
Palatin Technologies Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Palatin Technologies Inc Korelacja - Waluta/Towar
Palatin Technologies Inc Finanse
Annual | 2023 |
Przychody: | $4.85M |
Zysk brutto: | $4.44M (91.38 %) |
EPS: | $-2.53 |
FY | 2023 |
Przychody: | $4.85M |
Zysk brutto: | $4.44M (91.38 %) |
EPS: | $-2.53 |
FY | 2022 |
Przychody: | $1.47M |
Zysk brutto: | $1.25M (85.19 %) |
EPS: | $-3.75 |
FY | 2021 |
Przychody: | $-188 597 |
Zysk brutto: | $-336 437 (-178.39 %) |
EPS: | $-3.55 |
Financial Reports:
No articles found.
Palatin Technologies Inc
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej